Alkaline Fe(III) reduction by a novel alkali-tolerant Serratia sp. isolated from surface sediments close to Sellafield nuclear facility, UKTHORPE, Clare L; MORRIS, Katherine; BOOTHMAN, Christopher et al.FEMS microbiology letters. 2012, Vol 327, Num 2, pp 87-92, issn 0378-1097, 6 p.Article

Optimization of biological synthesis of silver nanoparticles using Lactobacillus casei subsp. caseiKORBEKANDI, Hassan; IRAVANI, Siavash; ABBASI, Sajjad et al.Journal of chemical technology and biotechnology (1986). 2012, Vol 87, Num 7, pp 932-937, issn 0268-2575, 6 p.Article

Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targetingDELAHOUSSAYE, Yvette M; HAY, Michael P; PRUIJN, Frederik B et al.Biochemical pharmacology. 2003, Vol 65, Num 11, pp 1807-1815, issn 0006-2952, 9 p.Article

Formation of DNA interstrand cross-links as a marker of mitomycin C bioreductive activation and chemosensitivityVOLPATO, Milène; SEARGENT, Jill; LOADMAN, Paul M et al.European journal of cancer (1990). 2005, Vol 41, Num 9, pp 1331-1338, issn 0959-8049, 8 p.Article

Pharmacological and biological evaluation of a series of substituted 1,4-naphthoquinone bioreductive drugsPHILLIPS, Roger M; JAFFAR, Mohammed; MAITLAND, Derek J et al.Biochemical pharmacology. 2004, Vol 68, Num 11, pp 2107-2116, issn 0006-2952, 10 p.Article

The catalytic promiscuity of a microbial 7α-hydroxysteroid dehydrogenase. Reduction of non-steroidal carbonyl compoundsYANG LIU; TONG LV; JIE REN et al.Steroids. 2011, Vol 76, Num 10-11, pp 1136-1140, issn 0039-128X, 5 p.Article

Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and IIROSENZWEIG, H. S; PAPADOPOULOU, M. V; BLOOMER, W. D et al.Oncology research. 2005, Vol 15, Num 4, pp 219-231, issn 0965-0407, 13 p.Article

Hydrogenation of C-C double bonds in an ionic liquid reaction system using the obligate anaerobe, Sporomusa termitidaLENOURRY, Alix; GARDINER, John M; STEPHENS, Gill et al.Biotechnology letters. 2005, Vol 27, Num 3, pp 161-165, issn 0141-5492, 5 p.Article

Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapiesSINGH, Simendra; GUPTA, Alok K.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 6, pp 1211-1224, issn 0344-5704, 14 p.Article

Reductive metabolism of the nitroimidazole-based hypoxia-selective cytotoxin NLCQ-1 (NSC 709257)PAPADOPOULOU, Maria V; MING JI; RAO, Mira K et al.Oncology research. 2003, Vol 14, Num 1, pp 21-29, issn 0965-0407, 9 p.Article

Bioreduction of α-chloroacetophenone by whole cells of marine fungiROCHA, Lenilson C; FERREIRA, Hercules V; PIMENTA, Eli F et al.Biotechnology letters. 2009, Vol 31, Num 10, pp 1559-1563, issn 0141-5492, 5 p.Article

Role of GRP58 in mitomycin C-induced DNA cross-linkingCELLI, Claudia M; JAISWAL, Anil K.Cancer research (Baltimore). 2003, Vol 63, Num 18, pp 6016-6025, issn 0008-5472, 10 p.Article

Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxiaHODGKISS, R. J.Anti-cancer drug design. 1998, Vol 13, Num 6, pp 687-702, issn 0266-9536Article

Bioreductive therapies : An overview of drugs and their mechanisms of actionRAUTH, A. M; MELO, T; MISRA, V et al.International journal of radiation oncology, biology, physics. 1998, Vol 42, Num 4, pp 755-762, issn 0360-3016Conference Paper

Rhodotorula minuta-mediated bioreduction of 1,2-diketonesMONSALVE, Leandro N; CERRUTTI, Patricia; GALVAGNO, Miguel A et al.Biocatalysis and biotransformation (Print). 2010, Vol 28, Num 2, pp 137-143, issn 1024-2422, 7 p.Article

Didymosphaeria igniaria: a new microorganism useful for the enantioselective reduction of aryl-aliphatic ketonesSWIZDOR, Alina; JANECZKO, Tomasz; DMOCHOWSKA-CLADYSZ, Jadwiga et al.Journal of industrial microbiology & biotechnology. 2010, Vol 37, Num 11, pp 1121-1130, issn 1367-5435, 10 p.Article

Removal of Nitrate and Hexavalent Uranium From Groundwater by Sequential Treatment in Bioreactors Packed With Elemental Sulfur and Zero-Valent IronLUNA-VELASCO, Antonia; SIERRA-ALVAREZ, Reyes; CASTRO, Beatriz et al.Biotechnology and bioengineering. 2010, Vol 107, Num 6, pp 933-942, issn 0006-3592, 10 p.Article

Reduction of Fe(II)EDTA-NO using Paracoccus denitrificans and changes of Fe(II)EDTA in the systemNING LI; YU ZHANG; YANMEI LI et al.Journal of chemical technology and biotechnology (1986). 2013, Vol 88, Num 2, pp 311-316, issn 0268-2575, 6 p.Article

Characteristics of a Novel Acinetobacter sp. and Its Kinetics in Hexavalent Chromium BioreductionNARAYANI, M; VIDYA, Shetty K.Journal of microbiology and biotechnology. 2012, Vol 22, Num 5, pp 690-698, issn 1017-7825, 9 p.Article

NLCQ-1 (NSC 709257): Exploiting hypoxia with a weak DNA-intercalating bioreductive drugPAPADOPOULOU, Maria V; BLOOMER, William D.Clinical cancer research. 2003, Vol 9, Num 15, pp 5714-5720, issn 1078-0432, 7 p.Article

A preclinical pharmacokinetic study of the bioreductive drug AQ4NLOADMAN, P. M; SWAINE, D. J; BIBBY, M. C et al.Drug metabolism and disposition. 2001, Vol 29, Num 4, pp 422-426, issn 0090-9556, 1Article

Progress in electron transfer reactions of new quinone bioreductive alkylating agentsVANELLE, Patrice; TERME, Thierry; GIRAUD, Luc et al.Recent research developments in organic chemistry. Vol. 4 (2000) - Part I. Recent research developments in organic chemistry. 2000, pp 1-28, isbn 81-86846-71-9, 28 p.Book Chapter

Intrinsic reactivity of tamoxifen and toremifene metabolites with DNAHELLMANN-BLUMBERG, U; CARTNER, M. G; WURZ, G. T et al.Breast cancer research and treatment. 1998, Vol 50, Num 2, pp 135-141, issn 0167-6806Article

Sensor/effector drug design with potential relevance to cancer : Cancer cell redox status: novel target for designing strategies to overcome apoptosis resistanceFRY, Fiona H; JACOB, Claus.Current pharmaceutical design. 2006, Vol 12, Num 34, pp 4479-4499, issn 1381-6128, 21 p.Article

Single-dose pharmacokinetics of the DNA-binding bioreductive agent NLCQ-1 (NSC 709257) in CD2F₁ miceREID, Joel M; SQUILLACE, David P; AMES, Matthew M et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 6, pp 483-487, issn 0344-5704, 5 p.Article